Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8722618 IL4/IL13 binding repeat proteins and uses

Patent 8722618 was granted and assigned to Janssen Biotech on May, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 1 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11970526 IL4/IL13 receptor molecule for veterinary use
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834504 DARPin based multi-specific t-cell engagers
0
Edits on 2 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 2 Dec, 2023
Edits made to:
Article (+440 characters)
Article

Patent abstract

IL4/IL13-binding proteins comprise binding domains, which inhibit IL4/IL13 binding to IL4Ralpaha and common gamma chain complexes (Type 1) and inhibit IL4 binding to IL4Ralpha and IL13Ralpha1 complexes (Type 2), and IL13 binding to IL13Ralpha1 and/or IL13Ralpha2, are useful in the treatment of cancer, inflammatory, and other pathological conditions, such as allergic or fibrotic conditions, especially pulmonary conditions.

Edits on 25 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Gaby Sennhauser0
Karyn O'Neil0
Michael Baumann0
Steven Jacobs0
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=087226180
Edits on 19 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08722618 IL4/IL13 binding repeat proteins and uses US Patent 8722618 IL4/IL13 binding repeat proteins and uses

Infobox
Patent Number
087226180
Patent Number
87226180
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Janssen Biotech
Janssen Biotech
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
087226180
Date of Patent
May 13, 2014
0
Patent Application Number
134585780
Date Filed
April 27, 2012
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=087226180
Patent Primary Examiner
‌
Karlheinz R. Skowronek
0
Edits on 19 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08722618
Edits on 23 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 23 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08722618 IL4/IL13 binding repeat proteins and uses

Infobox
Is a
Patent
Patent
Current assignee
Janssen Biotech
Janssen Biotech
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08722618
Date of patent
May 13, 2014
Patent application number
13458578
Date Filed
April 27, 2012
Patent primary examiner
‌
Karlheinz R. Skowronek

Find more entities like US Patent 8722618 IL4/IL13 binding repeat proteins and uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo